title: Potential therapeutic use of autologous human lymphocytes in metastatic melanoma: in vivo interleukin 2-activated peripheral blood lymphocytes and in vitro activated peripheral blood and tumor-infiltrating lymphocytes.
authors.affiliation: Division of Experimental Oncology D, Istituto Nazionale Tumori, Milan, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Parmiani
authors.forename: G
authors.initials: G
authors.lastname: Fossati
authors.forename: M
authors.initials: M
authors.lastname: Radrizzani
authors.forename: C
authors.initials: C
authors.lastname: Gambacorti-Passerini
authors.forename: R
authors.initials: R
authors.lastname: Marolda
authors.forename: N
authors.initials: N
authors.lastname: Cascinelli
mesh_terms: D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology*; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014182:Transplantation, Autologous
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins